close

Fundraisings and IPOs

1 2 3 78
Number of results: 1557
Date Company Amount Funding type Investors Therapeutic area Type of Information
2019-07-24 20Med Therapeutic (The Netherlands) undisclosed grant European Eurostars Programme (EU) Rheumatic diseases - Inflammatory diseases Grant
2019-07-19 Avrobio (USA - MA) $138.3 milion private placement Rare diseases - Genetic diseases Private placement
2019-07-19 Noxxon Pharma (Germany) € 0.521 million capital increase Cancer - Oncology Capital increase
2019-07-19 Medicxi (Switzerland) € 400 million financing round JJDC (USA) Novartis (Switzerland) undisclosed institutional limited partners and established hospital foundations and medical institutions Financing round
2019-07-18 Genmab (Denmark) IPO Cancer - Oncology - Rare diseases IPO
2019-06-04 Amicus Therapeutics (USA - NJ) $ 189 million private placement Rare diseases - Genetic diseases Private placement
2019-05-28 Ideaya Biosciences (USA - CA) $57.5 million IPO Cancer - Oncology IPO
2019-05-22 Locana (USA - CA) $ 55 million series A financing round ARCH Venture Partners (USA) Temasek (Singapore) Lightstone Ventures (USA - MA) UCB Ventures (Belgium) GV (formerly Google Ventures) (USA - CA) Rare diseases - Genetic diseases Series A financing round
2019-03-20 Flagship Pioneering (USA - MA) $824 million financing round undisclosed long-time limited partners, new institutional investors, family offices Financing round
2019-03-14 Axovant Sciences (US - NY) $40 million private placement Rare diseases - Genetic diseases - Neurological diseases - Neuromuscular diseases Private placement
2019-03-13 Antisense Therapeutics (Australia) $1.6 million private placement Rare diseases - Genetic diseases Private placement
2019-03-12 Acesion Pharma (Denmark) DKK 5 Million grant Innovation Fund Denmark (Denmark) Cardiovascular diseases Grant
2019-03-11 Snipr Biome (Denmark) $50 million (€43 million, DKK320 million) series A financing round Lundbeckfonden Emerge (Denmark) LSP (Netherlands) North-East Family Office (Denmark) Wellington Partners (Germany) Autoimmune diseases - Cancer - Oncology - Infectious diseases Series A financing round
2019-03-06 Beam Therapeutics (USA - MA) $135 million series B financing round ARCH Venture Partners (USA - IL) F-Prime Capital Partners (USA - MA) Eight Roads Ventures (China - India - USA) Omega Funds (USA - MA) Redmile Group (USA - CA) Cormorant Asset Management (USA - MA) GV (USA - CA) Altitude Life Science Ventures (USA - WA) and additional undisclosed investors Rare diseases - Genetic diseases Series B financing round
2019-02-27 MeiraGTx (USA - NY) $80 million private placement Johnson & Johnson Innovation – JJDC (USA - NJ) Perceptive Advisors (USA - NY) OrbiMed Advisors, (USA - NY) 683 Capital Management (USA - NY) Rare diseases - Genetic diseases Private placement
2019-02-25 Gensight Biologics (France) €8 million capital increase Sofinnova Crossover I SLP (Francep Rare diseases - Genetic diseases - Ophtalmological diseases Capital increase
2019-02-14 Passage Bio (USA - PA) $115.5 million series A financing round OrbiMed Advisors (USA - NY) Frazier Healthcare Partners (USA - WA) Versant Ventures (USA - CA) New Leaf Venture Partners (USA - NY - CA) Vivo Capital (USA - CA) Lilly Asia Ventures (China) Rare diseases - Genetic diseases - CNS diseases Series A financing round
2019-02-12 Neurogene (USA - NY) $68.5 million series A financing round Samsara BioCapital (USA - CA) EcoR1 Capital (USA - CA) Cormorant Asset Management (USA - MA) Redmile Group (USA - CA) undisclosed leading healthcare investment fund. Rare diseases - Genetic diseases - Neurological diseases Series A financing round
2019-01-25 Nordic Nanovector (Norway) NOK 222 million ($ 26 million) private placement Cancer - Oncology Private placement
2019-01-25 Corbus Pharmaceuticals (USA - MA) private placement Inflammatory diseases Private placement